Delivery Order SPE2DR25D2003-SPE2DR26FR07R
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,519.71 to AmerisourceBergen Drug Corp for Gvoke HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This firm fixed-price, competitively awarded contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order operates as a child contract under AmerisourceBergen's existing indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,066.98 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Gvoke Hypoepen 2-packs (0.5mg/0.1mL auto-injectors). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. The contract is scheduled for completion by December 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $2,558.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for Gvoke HypoPen 1-pack 1 mg/0.2 ml auto-injectors, with an ultimate completion date of December 8, 2025. The contract carries no set-aside designation and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL dosage). This is a firm fixed-price delivery order with a ceiling value of $10,843.19 and an ultimate completion date of August 26, 2025. The award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,734.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gvoke HypoPen auto-injectors (1 mg/0.2 ml, 2-pack). The contract, which represents a non-competitive delivery order under an existing indefinite delivery vehicle, will be fulfilled from the vendor's Conshohocken, Pennsylvania location with a completion date of September 10, 2025. This award is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gvoke HypoPen 1-mg/0.2-ml auto-injector pens with a ceiling value of $1,057.60 under a firm fixed price contract type. The award was made on November 7, 2025, with an ultimate completion date of November 10, 2025. This is a non-set-aside competitively awarded order, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.46 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gvoke HypoPen 2-pack (1 mg/0.2 mL) auto-injectors. The contract, which is not set aside and was competitively awarded, specifies a firm fixed price structure with an ultimate completion date of June 2, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $5,383.14 to AmerisourceBergen Drug Corp for the supply of Gvoke HyperPen 2-Pack 1 mg/0.2 ml auto-injectors on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gvoke HyperPen is an emergency glucagon auto-injector used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.47 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack auto-injectors (0.5mg/0.1ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a firm fixed price transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a glucagon emergency injection device used for treating severe...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gvoke HypoePen, a 2-pack auto-injector medication (1 mg/0.2 mL) with a ceiling value of $1,505.56. This firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-competitive award under the company's existing indefinite delivery contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR07RDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,109.11 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Gvoke HypoPen 1-Pack 1 mg/0.2 mL auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is a child contract executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying medications and medical supplies across multiple therapeutic domains to military and veteran healthcare systems. The Gvoke HypoPen is a glucagon auto-injector used for emergency treatment of severe hypoglycemia in patients with diabetes, representing the type of specialized medical commodity routinely delivered through the company's federal contract portfolio. The broader IDC vehicle enables efficient fulfillment of pharmaceutical requirements across military treatment facilities and other government healthcare institutions worldwide, with DLA Troop Support Medical managing the overall program to support global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/6/26 |